Molecular Markers and Prostate Cancer Radiation Response

2004 ◽  
Author(s):  
Mark A. Ritter
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Radiation Response

Molecular Markers and Prostate Cancer Radiation Response

2003 ◽  
Author(s):  
Mark A. Ritter
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Radiation Response

Molecular Markers in Prostate Cancer: The Role in Preoperative Staging

2002 ◽  
Vol 1 (1) ◽  
pp. 42-50 ◽  
Author(s):  
Judd W. Moul ◽  
Axel S. Merseburger ◽  
Shiv Srivastava
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Preoperative Staging

scholarly journals Molecular Markers and Death From Prostate Cancer

2009 ◽  
Vol 150 (9) ◽  
pp. 595 ◽  
Author(s):  
John Concato
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers

From Gene to Clinic: TMA-Based Clinical Validation of Molecular Markers in Prostate Cancer

2010 ◽  
pp. 177-189 ◽  
Author(s):  
Thorsten Schlomm ◽  
Felix KH Chun ◽  
Andreas Erbersdobler
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Clinical Validation

scholarly journals Molecular markers and determinants of prostate cancer metastasis

2001 ◽  
Vol 189 (3) ◽  
pp. 245-256 ◽  
Author(s):  
Rahul V. Gopalkrishnan ◽  
Dong-chul Kang ◽  
Paul B. Fisher
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Cancer Metastasis ◽  
Prostate Cancer Metastasis

MOLECULAR MARKERS FOR PROSTATE CANCER: OPTIMIZATION OF NON-INVASIVE DIAGNOSTICS

2018 ◽  
Vol 16 (3) ◽  
Author(s):  
E.I. Surkova ◽  
M.G. Gordiev ◽  
D.A. Viktorov ◽  
A.G. Nikitin ◽  
A.N. Toropovski
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Non Invasive ◽  
Invasive Diagnostics

Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers

The Prostate ◽  
2019 ◽  
Vol 79 (7) ◽  
pp. 709-719 ◽  
Author(s):  
Xueli Wang ◽  
Mei Qi ◽  
Jing Zhang ◽  
Xiubin Sun ◽  
Hongwei Guo ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Hormonal Therapy ◽  
Differential Response ◽  
Morphological Parameters ◽  
Neoadjuvant Hormonal Therapy

scholarly journals Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues

2013 ◽  
Vol 2013 ◽  
pp. 1-15 ◽  
Author(s):  
Tamara Sequeiros ◽  
Marta García ◽  
Melania Montes ◽  
Mireia Oliván ◽  
Marina Rigau ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Molecular Markers ◽  
Tumor Grade ◽  
Developed Countries ◽  
Response To Therapy ◽  
Tissue Samples ◽  
Formalin Fixed Paraffin ◽  
Formalin Fixed Paraffin Embedded ◽  
Ffpe Tissues ◽  
Formalin Fixed

Prostate cancer (PCa) is the most frequently diagnosed type of cancer in developed countries. The decisive method of diagnosis is based on the results of biopsies, morphologically evaluated to determine the presence or absence of cancer. Although this approach leads to a confident diagnosis in most cases, it can be improved by using the molecular markers present in the tissue. Both miRNAs and proteins are considered excellent candidates for biomarkers in formalin-fixed paraffin-embedded (FFPE) tissues, due to their stability over long periods of time. In the last few years, a concerted effort has been made to develop the necessary tools for their reliable measurement in these types of samples. Furthermore, the use of these kinds of markers may also help in establishing tumor grade and aggressiveness, as well as predicting the possible outcomes in each particular case for the different treatments available. This would aid clinicians in the decision-making process. In this review, we attempt to summarize and discuss the potential use of microRNA and protein profiles in FFPE tissue samples as markers to better predict PCa diagnosis, progression, and response to therapy.

Sign in / Sign up

Export Citation Format

Share Document